News Release
Biosimilar Drugs Could Generate $38.4 Billion in Savings over Five Years
Jan 10, 2022
Biosimilar drugs could drive down prices for expensive medicines used to treat illnesses such as cancer and rheumatoid arthritis, with savings estimated to be $38.4 billion or 5.9% of projected total U.S. spending on biologics from 2021 to 2025.